TRI-N-METHYLFRANGANINE_METHIODIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | KBEcsSHfqvs |
|---|---|
| InChI | InChI=1S/C29H46N4O4.HI/c1-18(2)16-23-27(34)30-15-14-21-10-12-22(13-11-21)37-26(20(5)6)25(29(36)31-23)32-28(35)24(17-19(3)4)33(7,8)9;/h10-15,18-20,23-26H,16-17H2,1-9H3,(H2-,30,31,32,34,35,36);1H/b15-14-;/t23-,24-,25-,26-;/m0./s1 |
| InChIKey | QSNNYDRMAQYWHR-MVLTULMUSA-N |
| Mol Weight | 642.6 g/mol |
| Molecular Formula | C29H47IN4O4 |
| Exact Mass | 642.264201 g/mol |
| Parent InChIKey | SWBNAPLEACSSSQ-IMOVIQFISA-N |
| Enantiomer InChIKey | QSNNYDRMAQYWHR-RWWAOOECSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
2-dimethylamino-N-[(10Z)-7-isobutyl-3-isopropyl-5,8-diketo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(15),10,12(16),13-tetraen-4-yl]-4-methyl-valeramide
Butanamide, 2-(dimethylamino)-3-methyl-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-
SANJOININE-G2
(S)-[(N',N')-DIMETHYLPHENYLALANYL]-(2S,3S)-3-(PARA-FORMYLPHENOXYLEUCYL)-(S)-LEUCINE
N-TERT.-BUTYLOXYCARBONYL-GLYCYL-(S-PALMITOYL)-L-CYSTEYL-L-THREONYL-L-LEUCYL-L-SERYL-L-ALANINE-CHOLINE-ESTER-BROMIDE;BOC-GLY-CYS(PAL)-THR-LEU-SER-A
[(DIMYRISTOYLGLYCEROXY)-ACETYL]-LYS-ARG-THR-LEU-ARG-OH
L-Phenylalanine, N-[N-[N2,N5-bis(trifluoroacetyl)-L-ornithyl]-o-(trifluoroacetyl)-D-allothreonyl]-, methyl ester
EMERICELLAMIDE_A
Hexapeptide boc-leu-tyr(bzl)-leu-val-cys(set)-gly-04
BOC-SER-(PO3PH2)-LEU-SER-(PO3PH2)-SER-(PO3PH2)-SER-(PO3PH2)-GLU-(OBZL)-GLU-(OBZL)-NHME
| Title | Journal or Book | Year |
|---|---|---|
| Absolute Configuration of Franganine | Journal of Natural Products | 2012 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.